SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-001573
Filing Date
2024-02-23
Accepted
2024-02-23 07:01:09
Documents
17
Period of Report
2024-02-21
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20240221x8k.htm   iXBRL 8-K 42798
2 EX-3.1 bpth-20240221xex3d1.htm EX-3.1 13657
3 EX-99.1 bpth-20240221xex99d1.htm EX-99.1 13307
4 GRAPHIC bpth-20240221xex99d1001.jpg GRAPHIC 13644
  Complete submission text file 0001558370-24-001573.txt   221234

Data Files

Seq Description Document Type Size
5 EX-101.SCH bpth-20240221.xsd EX-101.SCH 3153
6 EX-101.LAB bpth-20240221_lab.xml EX-101.LAB 16579
7 EX-101.PRE bpth-20240221_pre.xml EX-101.PRE 10521
18 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20240221x8k_htm.xml XML 5055
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 24667219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)